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Virulence of enterohemorrhagic Escherichia coli (EHEC) strains depends on production of Shiga toxins. These toxins are encoded
in genomes of lambdoid bacteriophages (Shiga toxin-converting phages), present in EHEC cells as prophages.The genes coding for
Shiga toxins are silent in lysogenic bacteria, and prophage induction is necessary for their efficient expression and toxin production.
Under laboratory conditions, treatment with UV light or antibiotics interfering with DNA replication are commonly used to induce
lambdoid prophages. Since such conditions are unlikely to occur in human intestine, various research groups searched for other
factors or agents that might induce Shiga toxin-converting prophages. Among other conditions, it was reported that treatment with
H
2
O
2
caused induction of these prophages, though with efficiency significantly lower relative to UV-irradiation or mitomycin C
treatment. A molecular mechanism of this phenomenon has been proposed. It appears that the oxidative stress represents natural
conditions provoking induction of Shiga toxin-converting prophages as a consequence of H
2
O
2
excretion by either neutrophils in
infected humans or protist predators outside human body. Finally, the recently proposed biological role of Shiga toxin production
is described in this paper, and the “bacterial altruism” and “Trojan Horse” hypotheses, which are connected to the oxidative stress,
are discussed.
1. Introduction: Enterohemorrhagic
Escherichia coli Strains and Shiga
Toxin-Converting Phages
Escherichia coli is a bacterial species commonly known as a
commensal occurring in the mammalian intestine [1]. This is
true in most cases; however, some E. coli strains are capable
of causing disease in humans. One example of pathogenic E.
coli is a series of strains called Shiga toxin-producing E. coli
(STEC) [2, 3].
Among STEC strains (defined as E. coli producing Shiga
toxins), the most dangerous for humans is the subset classi-
fied as enterohemorrhagic Escherichia coli (EHEC, defined as
E. coli causing bloody diarrhea) [2, 3]. Infection of humans by
EHEC strains causes hemorrhagic colitis (HC) and in some
patients it may result in various complications, including the
most severe of them, the hemolytic-uremic syndrome (HUS)
[2]. The most common symptoms of this syndrome are acute
renal failure, anemia, and thrombocytopenia; however, other
organs such as lung, pancreas, and heart may also be affected
[4]. Furthermore, some patients suffer from the disorders of
the central nervous system [4].
Themain virulence factors causing EHEC-mediatedHUS
are Shiga toxins, produced by the infecting bacteria. These
toxins are hexameric proteins, composed of a single A-
subunit and five identical B subunits [5]. The main receptor,
called Gb3 and occurring on the surface of many types of
eukaryotic cells, is recognized by the B-subunits. The toxin
enters cells by endocytosis, which is followed by its retrograde
transport from the early endosome through the Golgi-
apparatus and to the endoplasmic reticulum. The specific
proteolytic cleavage of the A-subunit results in the release of
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the A1 polypeptide from the A2 fragment attached to the B
pentamer. A1 is the actual toxin that is translocated from the
ER to the cytoplasm [6, 7]. The Shiga toxin A1 polypeptide
is an N-glycosidase that depurinates a single adenine residue
(A4324) within the 𝛼-sarcin/ricin loop of the 28S rRNA
[8, 9]. This modification results in an inhibition of amino-
acyl-tRNA binding to the ribosome and cessation of protein
synthesis, which leads to cell death [5].
Since cattle are resistant to Shiga toxins, due to the lack
of the Gb3 receptor, they serve as a natural reservoir of STEC
strains. However, any cattle-derived products contaminated
by STEC, and particularly EHEC, may cause severe human
infections, occurring usually as outbreaks. A few years ago
(in 2011) such an outbreak took place in Germany, where over
4,000 patients developed severe symptoms and 54 of them
died [10–15]. Contaminated fenugreek and lentil sprouts were
recognized as the source of the infection [13], indicating
that unwashed or improperly washed vegetables, especially
those coming from the so-called “ecological farming” where
only natural fertilizers (including those coming from cattle)
are used, may be a significant source of such outbreaks.
In that case, the strain of the O104:H4 serotype, which
caused the outbreak, had a combination of virulence factors
characteristic of enteroaggregative E. coli (EAEC) and EHEC
[12, 14]. The high virulence of this particular strain could
be ascribed to enhanced adhesion, survival adjustment,
antibiotic resistance, and Shiga toxin production [12].
Interestingly, genes coding for Shiga toxins (stx genes) are
located in genomes of prophages rather than in actual bac-
terial genome [16, 17]. Bacteriophages bearing the stx genes,
called Shiga toxin-converting phages or Stx phages, can
lysogenize E. coli strains making them STEC. All Stx phages
described to date belong to the family of lambdoid phages,
viruses having genomes organized in a manner similar to
that found in bacteriophage 𝜆 [17]. The genome of a lamb-
doid phage consists of blocks of genes coding for proteins
responsible for specific functions. This makes recombination
and exchange of genes between various phages relatively easy
and leads to mosaicism of genomes of lambdoid phages [18].
In genomes of Shiga toxin-converting phages, the stx genes
are present between the 𝑄 antiterminator gene and the genes
coding for proteins causing cell lysis (Figure 1(a)).
As long as the Stx bacteriophage is present in the E.
coli host as a prophage, vast majority of its genes, including
stx genes, are silent due to the repression caused by the
phage-encoded cI protein [19–21]. Under such conditions,
Shiga toxin is not produced. Effective expression of stx genes,
together with all genes required for lytic development of
the bacteriophage, occurs only after prophage induction,
though Shiga toxin 1 may also be produced under conditions
of low iron levels due to the presence of the Fe-sensitive
promoter upstream of the stx1 locus [17, 20]. The prophage
induction occurs generally due to activation of the bacterial
SOS response which is a defensive mechanism provoked
by any conditions causing appearance of single-stranded
DNA fragments.TheRecAprotein recognizes such fragments
and is activated to stimulate the self-cleavage of the LexA
repressor (bearing the peptidase domain in its structure),
which under normal conditions inhibits expression of the
SOS regulon (Figure 1(b)). However, the phage cI repressor
resembles LexA (Figure 2) and it is also degraded under the
SOS stress response, causing derepression of bacteriophage
promoters, excision of the prophage, and subsequent lytic
development of the virus. Importantly, in the case of Stx
phages, expression of the stx genes proceeds together with
other phage genes [17, 20, 21] (Figure 1(a)). It is worth
mentioning that RecA-independent induction of Shiga toxin-
converting prophages by chelating agents, like EDTA, has also
been reported [22]. In conclusion, production of Shiga toxins
requires induction of Stx prophages, caused by either any
stress conditions provoking the SOS response or by chelating
agents.
Under laboratory conditions, induction of lambdoid
prophages is relatively easy, and standard methods for the
efficient induction include UV-irradiation and treatment
with antibiotics that interfere with bacterial DNA replication,
like mitomycin C [20, 21]. Such treatments lead to prophage
excision in a large fraction, if not most, of lysogenic cells
in a bacterial population. Nevertheless, when infection of
humans by EHEC is analyzed, one should consider prophage
induction conditions which can naturally occur in human
intestine. Obviously UV-irradiation is very unlikely there,
and high concentrations of antibiotics may be administered
only to patients subjected to intensive therapy, while symp-
toms of EHEC infection appear also in nontreated persons.
Moreover, other inducers of prophage excision, like EDTA
[22], irradiation with 60Co [27], or high hydrostatic pressure
[28], are also unlikely to occur in the human gut. Therefore,
an important question arose: what are factors or agents
that can induce Shiga toxin-converting prophages in EHEC-
infected human intestine? Understanding the mechanism
of stimulation of Shiga toxin production might lead to
development of novel methods for prevention or treatment
of EHEC-caused diseases, as well as deciphering a biological
role for maintaining the Stx prophages in bacterial genomes.
2. Hydrogen Peroxide as an Inducer of
Shiga Toxin-Converting Prophages
There were various attempts to find conditions which both
induce Stx prophages and are likely to occur in the human gut.
Different conditions, factors, and agents (including high and
low temperatures, high salt concentrations, chelators, 60Co,
high hydrostatic pressure, nitric oxide, and starvation) were
tested, and the results of these studies have been summarized
[17]. Most of the tested conditions either did not induce
lambdoid prophages or were unlikely to occur in human
intestine.
Under conditions of bacterial infection, including infec-
tion of the human gut, neutrophils are the first cells of the
immune system which attack the pathogens. Among other
bactericidal mediators, neutrophils excrete hydrogen perox-
ide to weaken bacterial cells. This oxidative stress-inducing
agent is dangerous for bacteria that are much more sensitive
to it than eukaryotic cells. However, it was demonstrated that
such an action of neutrophils enhances production of Shiga
toxins by EHEC strains [29]. Subsequent studies indicated
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Figure 1: Schematic map of a Shiga toxin-converting phage genome. At the top of (a), regions bearing genes for particular phage functions
are shown (as they appear in a prophage). The region containing genes involved in regulation of phage development, DNA replication, Shiga
toxin production, and cell lysis is enlarged and shown in more detail. Major transcripts are shown by arrows, with arrowheads demonstrating
directionality of transcription, and promotersmarked by short vertical lines at the beginning of transcripts. Terminators aremarked by vertical
lines crossing the transcript lines. The cI repressor binds to 𝑜R1, 𝑜R2, and 𝑜R3 operator sites, repressing 𝑝L and 𝑝R promoters and stimulating
its own promoter 𝑝M. When DNA is damaged, single stranded DNA (ssDNA) fragments appear which are recognized by RecA protein. This
activates RecA to switch to the RecA∗ form, able to stimulate self-cleavage by the cI repressor. Inactivated cI can no longer repress 𝑝L and
𝑝R and 𝑝M is not activated. This leads to effective transcription from 𝑝L and 𝑝R, prophage excision, and expression of vast majority of phage
genes, including those coding for Shiga toxin. (b) represents a similar mechanism leading expression of the SOS regulon which under normal
growth conditions is repressed by the LexA protein. Phage cI repressor resembles LexA; thus under conditions of the SOS response, induction
of the prophage occurs.
that hydrogen peroxide, when added to cultures of bacteria
lysogenic for various Shiga toxin-converting phages, is a
potent inducer of the prophages [30]. This was true for
bacteriophage 𝜆 as well as for different Stx phages. Moreover,
the prophage induction was accompanied by synthesis of
considerable amounts of the fusion protein, encoded by a
gene located in the place of the natural 𝑠𝑡𝑥 locus [30]. Very
similar results were obtained when natural isolate of EHEC
was tested instead of laboratory strains. Again, hydrogen
peroxide-mediated induction of the Stx prophage and effi-
cient production of Shiga toxinwere observed [31].Therefore,
the oxidative stress, mediated by hydrogen peroxide, leads to
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Figure 2: Comparison of domain structures of E. coli LexA protein and cI repressors of bacteriophage 𝜆 [19] and Shiga toxin-converting
bacteriophage 933W [23, 24]. Two domains of these proteins are shown, and crucial amino acid residues are marked. Upon stimulation by
the activated form of RecA (RecA∗) both LexA and cI cleave their own molecules (at indicated positions) by the peptidase S24-like domains.
The models were prepared using the DOG 1.0: Illustrator of Protein Domain Structures software [25].
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Figure 3: The 𝑝R-𝑝M regions of phage 𝜆 and Shiga toxin-converting phage 933W. Structural elements of each promoter are indicated, and
𝑜R1, 𝑜R2, and 𝑜R3 operator sequences are marked. The OxyR binding to the 𝜆𝑝R-𝑝M region (demonstrated experimentally [26]) is shown as a
solid oval, and a putative (not verified experimentally) OxyR binding to the 933W 𝑝R-𝑝M region is suggested by a dashed oval.
stimulation of expression of 𝑠𝑡𝑥 genes. Since such conditions
can occur in human intestine, the oxidative stress is a likely
candidate for a natural inducer of Shiga toxin-converting
prophages.
An interesting observation in studies on both laboratory
Stx lysogens and natural isolates of EHEC was that the
maximal efficiency of prophage induction occurred at a final
H
2
O
2
concentration of 3mM, and further increases in H
2
O
2
concentrations caused a decrease in induction efficiency [30,
31]. Moreover, while prophage induction by UV-irradiation
or mitomycin C caused a lysis of bacterial cultures in a
few hours, no such phenomenon could be detected after
treatment with hydrogen peroxide [30]. Subsequent calcu-
lations of the efficiency of prophage induction have shown
that while low concentration (1 𝜇g/mL) of mitomycin C
caused initiation of the lytic phage development in about
10–30% of cells (depending on the kind of the Stx phage),
the value of this parameter was as low as 0.03–1.6% at the
Oxidative Medicine and Cellular Longevity 5
cIcI
Inactive OxyR
OxyR
o R
3
o R
2
o R
1
pM pR
o R
3
o R
2
o R
1
pM pR
crocI
+ −
crocI
−−
(a) Normal growth conditions
Active OxyR
OxyR
OxyR
o R
3
o R
2
o R
1
pM pR
o R
3
o R
2
o R
1
pM pR
cIcI
crocI
+ −
crocI
+ −
(b) Oxidative stress conditions
Figure 4: Amodel for OxyR-mediatedmodulation of lambdoid prophagemaintenance under normal growth conditions and oxidative stress.
Under normal growth conditions (a), theOxyR protein is inactive.The cI protein binds to 𝑜R1 and 𝑜R2 operators, repressing𝑝R and stimulating
𝑝M. At high concentrations, cI binds also to 𝑜R3 which caused repression of 𝑝M. Under oxidative stress conditions (b), OxyR is activated and
binds to the 𝑜R3 region.This stimulates binding of cI to 𝑜R1 and 𝑜R2, enhancing 𝑝R repression and 𝑝M stimulation, and when cI concentration
increases, 𝑝M repression is prevented by competitive binding to 𝑜R3 by OxyR. This results in higher activity of 𝑝M than that under normal
growth conditions, increased levels of cI, and more efficient maintenance of the prophage.
optimal (for prophage induction, i.e., 3mM) concentration of
hydrogen peroxide [32].Therefore, inH
2
O
2
-treated lysogenic
bacteria, only a very small fraction of cells (usually less than
1%) is induced for prophage excision and subsequent lytic
development. Since the rest of bacterial population in the
culture can grow and propagate due to resistance to infection
by the same phage as the prophage present inside the cell, it
is not possible to observe culture lysis.
Another question was what is the mechanism causing
the low efficiency of prophage induction under conditions of
oxidative stress? Studies on bacteriophage 𝜆, the best known
representative of lambdoid phages, indicated the factor
responsible for such a phenomenon. Since DNA sequences
of the regulatory regions of 𝜆 and Stx phages are very similar
[33], one can suppose that the processes occurring in these
phages are generally the same.
It was demonstrated that the prophage induction by
hydrogen peroxide is over 100 times more effective in cells
with deletion of the oxyR gene than in wild-type control [26].
The OxyR protein is a transcription factor acting as a major
regulator of the oxidative stress [34]. In the phageDNAregion
responsible for the control of maintenance of the prophage,
there are 3 sites for binding of the cI repressor, called 𝑜R1,
𝑜R2, and 𝑜R3 (Figure 3). Binding of the cI protein to 𝑜R1 and
𝑜R2 represses 𝑝R, the major promoter for expression of genes
required during the lytic development, but at the same time
stimulates transcription of the cI gene from the 𝑝M promoter.
At high concentrations of cI, this protein can bind also to
𝑜R3 which causes a repression of its own promoter 𝑝M [20]
(Figure 4).
Detailed molecular studies indicated that OxyR can bind
specifically to the region of the 𝑝M-𝑝R promoters (introduc-
tion ofmutations to the putative OxyR-binding site abolished
interactions of this protein with DNA), though with a weaker
affinity than to its own promoter [26]. Interestingly, in the
presence of OxyR, the cI protein interactions with 𝑜R1, 𝑜R2
were enhanced, while binding of this repressor to 𝑜R3 was
impaired. These results suggested that OxyR might stimulate
repression of 𝑝R and activation of 𝑝M but at the same time
downregulate repression of 𝑝M [26]. This would lead to a
considerably more efficient maintenance of the prophage due
to more efficient blocking of the 𝑝R promoter by abundant
cI. Indeed, studies with gene fusions showed that while
under normal growth conditions (when OxyR is inactive)
the activity of the 𝑝M promoter was similar in both oxyR+
and ΔoxyR strains, the oxidative stress conditions (treatment
6 Oxidative Medicine and Cellular Longevity
of cells with H
2
O
2
which activates OxyR) caused enhanced
transcription from 𝑝M in wild-type bacteria and decreased
in the ΔoxyR mutant [26]. Therefore, it appears that the
OxyR protein is responsible for the low efficiency of prophage
induction caused under conditions of the oxidative stress
(Figure 4).
3. The Oxidative Stress and Biological Role of
Shiga Toxin Production by STEC
There is an intriguing question regarding the biological role
of Shiga toxin production by STEC strains. As described in
preceding sections, expression of stx genes is effective only
after Shiga toxin-converting prophage induction. However,
this also results in subsequent lytic development of the
bacteriophage and eventual death of the host cell. Thus,
what can be a benefit for the bacterium from production
of Shiga toxin while it is linked to its death? On the other
hand, if toxin production was not beneficial for E. coli, one
should expect a positive selection of lysogenic bacteria with
mutations causing deficiency in prophage induction and thus
elimination of STECcells from the bacterial population. Since
this is not the case, it should be beneficial for STEC to produce
Shiga toxin.
It was suggested that STEC virulence in humans may be
coincidental with the biological role for Shiga toxin being
unrelated to human infection [35]. This hypothesis assumed
that synthesis of Shiga toxins by STEC may enhance survival
of bacteria in food vacuoles of protozoan predators. Interest-
ingly, such a phenomenon was demonstrated experimentally
[36]. Moreover, a bacterivorous, protozoan predator, Tetrahy-
mena thermophila, was shown to be killed when cocultured
with bacteria lysogenic with Stx bacteriophage [37]. However,
this killing did not occur in the presence of catalase, an
enzyme responsible for hydrogen peroxide breakdown [37].
In fact,Tetrahymena producesH
2
O
2
to damage bacterial cells
during attack by this predator [37]. This may be a successful
predatory strategy in the case of the vast majority of bacteria;
however, if STEC cells are being attacked, Shiga toxin-
converting prophages are induced due to action of hydrogen
peroxide (as demonstrated experimentally [30, 31]), Shiga
toxin is produced, and after toxin release from E. coli due
to phage-mediated cell lysis, it kills the predator. The crucial
point of such a defensive bacterial strategy is a low effective
prophage induction by H
2
O
2
which has also been shown
[30, 31]. Therefore, of the total STEC population, only 1% or
less is lost for production of Shiga toxin (which is enough to
produce relatively large amounts of the toxin, sufficient to kill
the predator) while the rest of bacteria are saved.When STEC
infects human intestine, neutrophils’ action is similar to that
of protist predators, and H
2
O
2
is produced to kill bacteria
[38], but the effects are analogous to the Tetrahymena-STEC
interplay. The hypothesis on such an “bacterial altruism” has
been proposed independently by two groups [17, 39], and
detailed analyses of the literature indicated that the predicted
scenario may be true [32]. Moreover, the hypothesis has been
further confirmed by recent discoveries that STEC strains
are more resistant to the impact of grazing protists than E.
coli devoid of the stx genes [40] and that bacteriophage-
mediated lysis of STEC is necessary for killing of protist cells
by Shiga toxin, since the toxin released as a consequence of
digestion of bacteria by Tetrahymena is harmless to it [41].
The latter finding was the argument to call the STEC cells a
“TrojanHorse,” carrying genes encoding the toxin into target
organisms [42].
4. Concluding Remarks
The oxidative stress plays a pivotal role in the production of
Shiga toxins in cells of enterohemorrhagic Escherichia coli
(EHEC) infecting human intestine, as well as in response to
the attack of predator protists. In both cases, hydrogen per-
oxide is excreted by eukaryotic cells (either protist predators
or neutrophils in an infected organism) to weaken bacteria
which is a successful strategy against most prokaryotes; how-
ever, EHEC strains are lysogenic for Shiga toxin-converting
prophages, and H
2
O
2
stimulates their induction. This leads
to the switch to lytic development and production of the
toxin. It appears that Shiga toxin-producing bacteria use the
specific strategy of “bacterial altruism,” based on the OxyR-
mediated low efficiency of prophage induction during the
oxidative stress. As a consequence, only a small fraction of
bacterial cells is destroyed due to prophage induction, which
is nevertheless sufficient to produce relatively large amounts
of Shiga toxins able to kill eukaryotic cells. In this way the rest
of the E. coli population can survive the attack of the predator
or neutrophils.
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